Abstract

A 42-year–old young man had a tobacco chewing habit of more than 20 years. On the basis of micronuclei (MN) score 26, he was persuaded to quit

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Micronucleus assay in buccal smears of breast carcinoma patients
Pranab Dey ... Shaily Susheilia
Diagnostic Cytopathology | VOL. 40
Pranab Dey, et. al.Pranab Dey ... Shaily Susheilia
31 Dec 2010
Role of micronucleus scoring in buccal smears of carcinoma breast cases - A study in rural central India
Abhayvilas Deshmukh ... Vitaladevunibalasubramanyam Shivkumar
Clinical Cancer Investigation Journal | VOL. 9
Abhayvilas Deshmukh, et. al.Abhayvilas Deshmukh ... Vitaladevunibalasubramanyam Shivkumar
01 Jan 2020
Micronucleus Score in the Buccal Mucosa of Women with Breast Cancer and the Relationship to Chemotherapy
...
-
, et. al. ...
23 Oct 2015
The role of micronucleus scoring in fine needle aspirates of ductal carcinoma of the breast
R Nijhawan ... S Samanta
Cytopathology | VOL. 22
R Nijhawan, et. al.R Nijhawan ... S Samanta
23 Mar 2011
View more papers

More From: International Journal of Molecular and Immuno Oncology

Paper Title
Journal
Date
Author
Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer
Akhil Kapoor
International Journal of Molecular and Immuno Oncology | VOL. 9
Akhil KapoorAkhil Kapoor
19 Feb 2024
Understanding immunotherapy and CAR-T-cells: A narrative review
Mohammadi Maahtaab
International Journal of Molecular and Immuno Oncology | VOL. 9
Mohammadi MaahtaabMohammadi Maahtaab
19 Feb 2024
Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma - A perspective article
Mukul Arvind Gharote
International Journal of Molecular and Immuno Oncology | VOL. 9
Mukul Arvind GharoteMukul Arvind Gharote
19 Feb 2024
High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective
Mukul Arvind Gharote
International Journal of Molecular and Immuno Oncology | VOL. 9
Mukul Arvind GharoteMukul Arvind Gharote
19 Feb 2024
View more papers